The ongoing establishment of The Global Health Network's 'COVID-19 Working Groups' aims to address the discussion and gather consensus on the emerging COVID-19 research gaps across low-resource settings. This working group is set up to work around ways to enable better disease characterisation.
Around 200 researchers from across the globe working or wanting to work in disease characterisation have come together in this group to discuss ideas, form collaborations, access funding as well as share outputs and resources that others can use. There is so much experience that can be applied here - let's use that to help this immediate need to supporting research everywhere there are cases, now!
On the 22nd May, The Global Health Network supported the first virtual team meeting for the ‘Diseases Characterisation Open Working Group’. The meeting was organised in response to questions raised in our recent COVID-19 workshops which highlighted the need for greater discussion of the impact that COVID-19 pandemic might have around COVID-19 disease characterisation, specifically the implications for co-infection, immunology, etc.
After a meeting with the team leaders on the 15th July, incorporating the comments and action points from the first meeting’s report, it was agreed that the best plan of action will be to merge the write one protocol one which can be used by members of this WG in their respective countries and all around the world. A questionnaire was disseminated to all WG members to allow them to express their ideas concerning the above protocol.
A first draft protocol and a DCF was developed by the group leaders.These were shared with the whole team and posted on this page (at the bottom) for the rest of the members to comment by the 27th of August. Comments have been collated and are now being reviewed by the coordination team.
They plan to hold another zoom call with the whole team in the next few weeks.
Disease Characterisation Resources
As part of the COVID-19 Research Implementation Hub,
Here you are able to find all the working documents from the different WGs for you to comment on;
If you are interesting please register here and we will be in touch!
We look forward to hearing back from you and hope we can work together to support a strong and equitable global research response during this Pandemic
In collaboration with WHO, the ISARIC consortium have developed the Clinical Characterisation Protocol (CCP) which is designed for investigating any severe or potentially severe acute infection of public health interest.
It is a standardised protocol that enables data and biological samples to be collected rapidly in a globally-harmonised manner.
The Clinical Characterisation Protocol (CCP) can be used for the rapid, coordinated clinical investigation of confirmed cases of COVID-19.
In addition to these resources, the following series of short video tutorials are designed to cover the overview, key steps and considerations for implementation of the CCP study by research teams globally.
For more information and access to all of the resources and documents featured in these video tutorials, please visit the ISARIC COVID-19 Clinical Research Resources